Ramassamy C., Christen Y., Poirier J. (2001). Beta-amyloid peptide and apolipoprotein E in Alzheimer's disease . Dans Christen Y. (Éd.) , Advances in Ginko Biloba Extracts Research (pp. 72-89). Solal.

Ramassamy C., Krzywkowski P., Averill D., Lussier-Cacan S., Theroux L., Christen Y., Davignon J., Poirier J. (2001). Impact of apoE deficiency on oxidative insults and antioxidant levels in the brain, Brain Res Mol Brain Res, 86(1-2), 76-83.

Redrobe J. P., Quirion R. (2001). Neuropeptide Y (NPY) as a potential target for the treatment of depressive illness: Y not?, Neurosci News, 4, 61-68.

Rockwood K., Black S., Gauthier S., Feldman H., Wentzell C. (2001). Clinical and neuroimaging findings in mixed dementia, Res Pract Alzheimer Dis, 5, 115-122.

Stage K. B., Bech P., Kragh-Sorensen P., Nair N., Katona C. (2001). Differences in symptomatology and diagnostic profile in younger and elderly depressed inpatients, J Affect Disord, 64(2-3), 239-48.

Tomossy G. F., Weisstub D. N., Gauthier S. (2001). Regulating ethical research involving cognitively impaired elderly subjects. Canada as a case study . Dans Weisstub D. N., Thomasma D. C., Gauthier S., Tomossy G. F. & Weisstub D. N. (Éds.) , Aging: Decisions at the End of Life (pp. 227-254). Kluwer Academic Publishers..

Valastro B., Ghribi O., Poirier J., Krzywkowski P., Massicotte G. (2001). AMPA receptor regulation and LTP in the hippocampus of young and aged apolipoprotein E-deficient mice, Neurobiol Aging, 22(1), 9-15.

Vaucher E., Aumont N., Pearson D., Rowe W., Poirier J., Kar S. (2001). Amyloid beta peptide levels and its effects on hippocampal acetylcholine release in aged, cognitively-impaired and -unimpaired rats, J Chem Neuroanat, 21(4), 323-9.

Wentzel C., Rockwood K., MacKnight C., Hachinski V., Hogan D. B., Feldman H., Ostbye T., Wolfson C., Gauthier S., Verreault R., McDowell I. (2001). Progression of impairment in patients with vascular cognitive impairment without dementia, Neurology, 57(4), 714-6.

Winblad B., Brodaty H., Gauthier S., Morris J. C., Orgogozo J. M., Rockwood K., Schneider L., Takeda M., Tariot P., Wilkinson D. (2001). Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?, Int J Geriatr Psychiatry, 16(7), 653-66.

Wood G. K., Marcotte E. R., Quirion R., Srivastava L. (2001). Strain differences in the behavioural outcome of neonatal ventral hippocampal lesions are determined by the postnatal environment and not genetic factors, Eur J Neurosci, 14(6), 1030-4.

de Leon M. J., Convit A., Wolf O. T., Tarshish C. Y., DeSanti S., Rusinek H., Tsui W., Kandil E., Scherer A. J., Roche A., Imossi A., Thorn E., Bobinski M., Caraos C., Lesbre P., Schlyer D., Poirier J., Reisberg B., Fowler J. (2001). Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET), Proc Natl Acad Sci U S A, 98(19), 10966-71.